Loading
Latest filing published 20 Feb 2020 for Cannara Biotech Inc. (formerly, Dunbar Capital Corp.).
No signal scores available.
All filings by Barnett Laxer on record concern Cannara Biotech Inc. (formerly, Dunbar Capital Corp.). We count 2 filings; the first trade dates from 14 August 2019 and the latest from 19 February 2020.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 20 February 2020 with a transaction in Cannara Biotech Inc. (formerly, Dunbar Capital Corp.). This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations